Literature DB >> 18996575

Prostaglandin E receptor subtype EP3 in conjunctival epithelium regulates late-phase reaction of experimental allergic conjunctivitis.

Mayumi Ueta1, Toshiyuki Matsuoka, Shuh Narumiya, Shigeru Kinoshita.   

Abstract

BACKGROUND: We previously demonstrated that the prostaglandin E(2) (PGE(2))-EP3 pathway negatively regulates allergic reactions in a murine allergic asthma model.
OBJECTIVES: We investigated whether the PGE(2)-EP3 pathway also regulates the development of murine experimental allergic conjunctivitis (EAC).
METHODS: The expression of EP3 was examined by means of RT-PCR and immunohistochemistry in wild-type mice, as well as by means of 5-bromo-4-chloro-3-indolyl-beta-D-galactopyranoside staining in mice deficient in EP3 (Ptger3(-/-) mice) carrying the beta-galactosidase gene at the EP3 gene locus. EAC was induced by immunization of mice with short ragweed pollen (RW), followed by challenge with eye drops of RW, and eosinophil infiltration and eotaxin-1 mRNA expression in the conjunctiva were examined. Mice were also treated with a topical application of an EP3-selective agonist during the elicitation phase. Quantitative RT-PCR was used to detect expression of COXs and prostaglandin E synthases, and ELISA was used to measure PGE(2) production in the eyelid.
RESULTS: EP3 was constitutively expressed in conjunctival epithelium on the ocular surface. Ptger3(-/-) mice demonstrated significantly increased eosinophil infiltration in conjunctiva after RW challenge compared with wild-type mice. Consistently, significantly higher expression of eotaxin-1 mRNA was observed in Ptger3(-/-) mice. Conversely, treatment of wild-type mice with an EP3-selective agonist resulted in a significant decrease in eosinophil infiltration, which was blunted in Ptger3(-/-) mice. Expression of COX-2 and prostaglandin E synthases was upregulated and PGE(2) content was increased in the eyelids after RW challenge.
CONCLUSION: These data suggest that PGE(2) acts on EP3 in conjunctival epithelium and downregulates the progression of EAC.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18996575     DOI: 10.1016/j.jaci.2008.09.044

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  15 in total

1.  Expression of interleukin-4 receptor α in human corneal epithelial cells.

Authors:  Mayumi Ueta; Chie Sotozono; Shigeru Kinoshita
Journal:  Jpn J Ophthalmol       Date:  2011-05-27       Impact factor: 2.447

2.  Human Leukocyte Antigen Class I Genes Associated With Stevens-Johnson Syndrome and Severe Ocular Complications Following Use of Cold Medicine in a Brazilian Population.

Authors:  Tais H Wakamatsu; Mayumi Ueta; Katsushi Tokunaga; Yukinori Okada; Renata R Loureiro; Karita A Costa; Juliana Maria F Sallum; José Arthur Milhomens; Chikara Inoue; Chie Sotozono; José Álvaro P Gomes; Shigeru Kinoshita
Journal:  JAMA Ophthalmol       Date:  2017-04-01       Impact factor: 7.389

3.  Expression of prostaglandin E2 receptor subtypes in human pterygium and normal conjunctiva: immunohistochemical study.

Authors:  Erdem Dinç; Özer Dursun; Banu Yılmaz; Mustafa Vatansever; A Ayça Sarı; Özlem Yıldırım; Ufuk Adıgüzel
Journal:  Int Ophthalmol       Date:  2017-07-10       Impact factor: 2.031

4.  Selective activation of the prostaglandin E2 circuit in chronic injury-induced pathologic angiogenesis.

Authors:  Elvira L Liclican; Van Nguyen; Aaron B Sullivan; Karsten Gronert
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-07-07       Impact factor: 4.799

5.  Neuronal prostaglandin E2 receptor subtype EP3 mediates antinociception during inflammation.

Authors:  Gabriel Natura; Karl-Jürgen Bär; Annett Eitner; Michael K Boettger; Frank Richter; Susanne Hensellek; Andrea Ebersberger; Johannes Leuchtweis; Takayuki Maruyama; Gunther Olaf Hofmann; Karl-Jürgen Halbhuber; Hans-Georg Schaible
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-31       Impact factor: 11.205

Review 6.  Prostanoids and inflammation: a new concept arising from receptor knockout mice.

Authors:  Shuh Narumiya
Journal:  J Mol Med (Berl)       Date:  2009-07-17       Impact factor: 4.599

7.  Inhibition of prostaglandin E2 receptor EP3 mitigates thrombin-induced brain injury.

Authors:  Xiaoning Han; Xi Lan; Qiang Li; Yufeng Gao; Wei Zhu; Tian Cheng; Takayuki Maruyama; Jian Wang
Journal:  J Cereb Blood Flow Metab       Date:  2015-10-02       Impact factor: 6.200

8.  Prostaglandin E receptor subtype EP3 expression in human conjunctival epithelium and its changes in various ocular surface disorders.

Authors:  Mayumi Ueta; Chie Sotozono; Norihiko Yokoi; Tsutomu Inatomi; Shigeru Kinoshita
Journal:  PLoS One       Date:  2011-09-22       Impact factor: 3.240

9.  Prostaglandin E2-EP3 axis in fine-tuning excessive skin inflammation by restricting dendritic cell functions.

Authors:  Noriko Shiraishi; Takashi Nomura; Hideaki Tanizaki; Saeko Nakajima; Shuh Narumiya; Yoshiki Miyachi; Yoshiki Tokura; Kenji Kabashima
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

Review 10.  Cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis with severe ocular complications-phenotypes and genetic predispositions.

Authors:  Mayumi Ueta
Journal:  Taiwan J Ophthalmol       Date:  2016-08-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.